There are 2867 resources available
Q&A
Presenter: Aditya Bardia
Session: F. Hoffman-La Roche LTD - What, why and how: Expert review and opinions on the potential of oral SERDs for our patients with HR+ BC
Resources:
Webcast
Q&A and discussiond
Presenter: All Speakers
Session: ESMO Colloquium Supported by Daiichi-Sankyo and AstraZeneca: Targeting HER2 in advanced breast cancer: Successes and perspectives
Resources:
Webcast
Conclusions
Presenter: Diana Lüftner
Session: Seagen - Expert Opinion: Considerations for Managing HER2+ Breast Cancer and Brain Metastases
Resources:
Webcast
Discussion
Presenter: All Speakers
Session: Supporting Ukraine: The European cancer advocacy community responds
Resources:
Slides
Webcast
Close
Presenter: Nick Turner
Session: F. Hoffman-La Roche LTD - What, why and how: Expert review and opinions on the potential of oral SERDs for our patients with HR+ BC
Resources:
Webcast
TILs
Presenter: Inge-Marie Svane
Session: Cellular therapies for solid tumours
Resources:
Slides
Webcast
Introduction and scientific background
Presenter: Pasi Jänne
Session: Creating a new stage between early and metastatic cancers: Illustration with lung cancers
Resources:
Slides
Webcast
650O - A phase II study of nivolumab for high-risk oral leukoplakia
Presenter: Glenn Hanna
Session: Proffered Paper session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
1529MO - The genomic landscape of small cell lung cancer in never smoking patients
Presenter: Michael Oh
Session: Mini Oral session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1488MO - Initial results of phase II/III trial of AL102 for treatment of desmoid tumors (DT)
Presenter: Robin Jones
Session: Mini Oral session: Sarcoma
Resources:
Abstract
Slides
Webcast